Ideal Medical Technologies (“IMT” or the “Company”) is a highly innovative medical device company focused on the development and sale of an Artificial Pancreas device utilizing novel Artificial Intelligence at the patient bedside in the ICU. FUSION is a new Artificial Pancreas to be used in the ICU to monitor, adjust, and improve glucose control for very sick, unstable and recovering critically ill patients.